<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>OXtal: An All-Atom Diffusion Model for Organic Crystal Structure Prediction - Health AI Hub</title>
    <meta name="description" content="OXtal introduces a novel, large-scale all-atom diffusion model for accurately predicting 3D molecular crystal structures from 2D chemical graphs, a long-standin">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>OXtal: An All-Atom Diffusion Model for Organic Crystal Structure Prediction</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.06987v1" target="_blank">2512.06987v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-07
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Emily Jin, Andrei Cristian Nica, Mikhail Galkin, Jarrid Rector-Brooks, Kin Long Kelvin Lee, Santiago Miret, Frances H. Arnold, Michael Bronstein, Avishek Joey Bose, Alexander Tong, Cheng-Hao Liu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cond-mat.mtrl-sci
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.06987v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.06987v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">OXtal introduces a novel, large-scale all-atom diffusion model for accurately predicting 3D molecular crystal structures from 2D chemical graphs, a long-standing challenge in computational chemistry. By utilizing a unique lattice-free training scheme and data augmentation, it achieves orders-of-magnitude improvements in accuracy and efficiency over prior methods, holding significant implications for pharmaceutical development.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate crystal structure prediction is paramount in pharmaceuticals, as crystal packing directly dictates critical drug properties such as solubility, bioavailability, stability, and formulation. OXtal's ability to rapidly and accurately predict these structures can significantly accelerate drug discovery and development by enabling efficient screening and optimization of drug candidates, leading to more effective and safer medications.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The OXtal diffusion model is an AI application that can accurately predict the 3D crystal structures of organic molecules. In the context of health, this enables more efficient and cost-effective identification and characterization of potential drug candidates. By predicting how drug molecules will pack into crystals, researchers can better understand and optimize critical properties such as solubility, bioavailability, stability, and manufacturability, thereby accelerating the drug development process and potentially leading to more effective and safer medications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Addresses a Core Challenge:** Solves the difficult and critical problem of Crystal Structure Prediction (CSP) for organic molecules, which directly impacts material properties.</li>
                    
                    <li>**Novel All-Atom Diffusion Model:** Introduces OXtal, a 100M parameter all-atom diffusion model that directly learns the conditional joint distribution over intramolecular conformations and periodic packing.</li>
                    
                    <li>**Innovative Lattice-Free Training:** Proposes Stoichiometric Stochastic Shell Sampling ($S^4$), a novel crystallization-inspired, lattice-free training scheme that efficiently captures long-range interactions without explicit lattice parametrization, enabling scalable all-atom resolution.</li>
                    
                    <li>**Enhanced Scalability and Efficiency:** Achieves scalability by employing data augmentation strategies instead of explicit equivariant architectures, making it computationally more efficient.</li>
                    
                    <li>**Superior Performance Metrics:** Recovers experimental structures with high fidelity, demonstrated by conformer $	ext{RMSD}_1 < 0.5$ √Ö and over 80% packing similarity rate.</li>
                    
                    <li>**Significant Outperformance:** Shows orders-of-magnitude improvements over prior *ab initio* machine learning CSP methods and is orders of magnitude cheaper than traditional quantum-chemical approaches.</li>
                    
                    <li>**Comprehensive Modeling Capability:** Effectively models both the thermodynamic stability and kinetic regularities of molecular crystallization, crucial for understanding crystal formation and properties.</li>
                    
                    <li>**Large-scale Data Leveraging:** Trained on a large dataset of 600K experimentally validated crystal structures, including diverse molecular types like rigid, flexible, co-crystals, and solvates.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>OXtal is a 100M parameter all-atom diffusion model designed to learn the conditional joint distribution of intramolecular conformations and periodic packing. It utilizes data augmentation strategies to achieve scalability, bypassing explicit equivariant architectures. A novel lattice-free training scheme, Stoichiometric Stochastic Shell Sampling ($S^4$), is employed to efficiently capture long-range interactions without explicit lattice parametrization. The model was trained on a large dataset comprising 600K experimentally validated crystal structures.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>OXtal successfully recovers experimental crystal structures with high accuracy, evidenced by a conformer $	ext{RMSD}_1 < 0.5$ √Ö and over 80% packing similarity rate. This performance marks orders-of-magnitude improvement over existing *ab initio* machine learning CSP methods and is substantially more cost-effective than traditional quantum-chemical approaches. The model demonstrates a robust capability to capture both the thermodynamic stability and kinetic aspects of molecular crystallization.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology holds the potential to profoundly impact pharmaceutical research and development by enabling rapid and reliable identification of the most stable and therapeutically optimal polymorphic forms of drug candidates. This can lead to improved drug formulations (e.g., enhanced dissolution rates, extended shelf-life), reduced development costs, faster time-to-market for new drugs, and better management of intellectual property related to specific crystal forms, ultimately benefiting patient outcomes through more effective and accessible medications.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations or caveats regarding the OXtal model or its methodology.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly suggest specific future research directions for OXtal.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmaceuticals</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Crystal Structure Prediction</span>
                    
                    <span class="tag tag-keyword">Diffusion Models</span>
                    
                    <span class="tag tag-keyword">Organic Crystals</span>
                    
                    <span class="tag tag-keyword">Computational Chemistry</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Pharmaceuticals</span>
                    
                    <span class="tag tag-keyword">Drug Discovery</span>
                    
                    <span class="tag tag-keyword">All-Atom Modeling</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Accurately predicting experimentally-realizable 3D molecular crystal structures from their 2D chemical graphs is a long-standing open challenge in computational chemistry called crystal structure prediction (CSP). Efficiently solving this problem has implications ranging from pharmaceuticals to organic semiconductors, as crystal packing directly governs the physical and chemical properties of organic solids. In this paper, we introduce OXtal, a large-scale 100M parameter all-atom diffusion model that directly learns the conditional joint distribution over intramolecular conformations and periodic packing. To efficiently scale OXtal, we abandon explicit equivariant architectures imposing inductive bias arising from crystal symmetries in favor of data augmentation strategies. We further propose a novel crystallization-inspired lattice-free training scheme, Stoichiometric Stochastic Shell Sampling ($S^4$), that efficiently captures long-range interactions while sidestepping explicit lattice parametrization -- thus enabling more scalable architectural choices at all-atom resolution. By leveraging a large dataset of 600K experimentally validated crystal structures (including rigid and flexible molecules, co-crystals, and solvates), OXtal achieves orders-of-magnitude improvements over prior ab initio machine learning CSP methods, while remaining orders of magnitude cheaper than traditional quantum-chemical approaches. Specifically, OXtal recovers experimental structures with conformer $\text{RMSD}_1<0.5$ √Ö and attains over 80\% packing similarity rate, demonstrating its ability to model both thermodynamic and kinetic regularities of molecular crystallization.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>